1. Home
  2. MEG vs KALV Comparison

MEG vs KALV Comparison

Compare MEG & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$21.01

Market Cap

930.8M

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$19.52

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
KALV
Founded
2012
N/A
Country
United States
United States
Employees
3500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.8M
1.0B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
MEG
KALV
Price
$21.01
$19.52
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$35.25
$32.60
AVG Volume (30 Days)
224.3K
1.2M
Earning Date
05-05-2026
05-09-2026
Dividend Yield
N/A
N/A
EPS Growth
93.69
N/A
EPS
N/A
N/A
Revenue
$830,538,000.00
$50,000,000.00
Revenue This Year
$5.41
$185.42
Revenue Next Year
$7.19
$59.23
P/E Ratio
N/A
N/A
Revenue Growth
19.26
495.66
52 Week Low
$14.16
$9.83
52 Week High
$32.00
$21.31

Technical Indicators

Market Signals
Indicator
MEG
KALV
Relative Strength Index (RSI) 38.19 52.52
Support Level N/A $14.66
Resistance Level $23.67 $21.31
Average True Range (ATR) 0.90 1.11
MACD -0.04 -0.13
Stochastic Oscillator 9.23 15.71

Price Performance

Historical Comparison
MEG
KALV

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: